Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume:1004.9
2.62
0  (0%)
Announcement & Circular
11-11
2024
APPROVAL OBTAINED FOR CLASS 1 INNOVATIVE ANTIDEPRESSANT LY03021 FOR CLINICAL TRIALS IN CHINA
11-01
2024
OVERSEAS REGULATORY ANNOUNCEMENT
11-01
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
10-30
2024
COMPLETION OF THE ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
10-28
2024
CHANGE OF CLOSING DATE OF THE ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
10-23
2024
PROPOSED ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025 AND US$50,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
10-02
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
09-04
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
08-28
2024
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
08-15
2024
NOTICE OF BOARD MEETING
1
2
3
4
5